Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 71.61% is in line with its 5-year average of 68.02%, around the middle of its 5-year range (30.46%–102.71%).
0.25% above its 12-month average of 71.43%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 73.18%.
GROSS MARGIN
71.61%
GROSS MARGIN AVG TTM
71.43%
GROSS MARGIN AVG 3Y
71.02%
GROSS MARGIN AVG 5Y
68.02%
GROSS MARGIN AVG 10Y
65.69%
GROSS MARGIN AVG 15Y
62.65%
GROSS MARGIN AVG 20Y
42.20%
CURRENT VS TTM AVG
+0.25%
CURRENT VS 3Y AVG
+0.83%
CURRENT VS 5Y AVG
+5.27%
CURRENT VS 10Y AVG
+9.01%
CURRENT VS 15Y AVG
+14.29%
CURRENT VS 20Y AVG
+69.67%
SECTOR MEDIAN · HEALTHCARE
43.54%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
+64.47%
vs the sector median at left
Cytosorbents Corporation
Market Cap
$12.16M
Gross Margin
71.61%
TTM Avg
71.43%
3Y Avg
71.02%
5Y Avg
68.02%
Market Cap
$12.41M
Gross Margin
36.23%
TTM Avg
36.65%
3Y Avg
39.59%
5Y Avg
41.13%
Market Cap
$12.58M
Gross Margin
-137.55%
TTM Avg
-73123.88%
3Y Avg
-36779.95%
5Y Avg
-24519.97%
Market Cap
$11.67M
Gross Margin
18.76%
TTM Avg
9.38%
3Y Avg
50.69%
5Y Avg
33.79%
Market Cap
$12.78M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.42M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.38M
Gross Margin
14.12%
TTM Avg
57.06%
3Y Avg
28.53%
5Y Avg
19.02%
Market Cap
$11.30M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
-4489.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.16M | 71.61% | 71.43% | 71.02% | 68.02% |
| IRIDEX Corporation (IRIX)vs › | $12.41M | 36.23% | 36.65% | 39.59% | 41.13% |
| Lantern Pharma Inc. (LTRN)vs › | $11.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | -137.55% | -73123.88% | -36779.95% | -24519.97% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.67M | 18.76% | 9.38% | 50.69% | 33.79% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | 14.12% | 57.06% | 28.53% | 19.02% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | 0.00% | 50.00% | 25.00% | -4489.78% |
| Biofrontera Inc. (BFRI)vs › | $11.04M | 84.45% | 64.39% | 56.15% | 53.94% |
Gross Margin
71.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 73.18% |
| 2026-03-31 | 69.16% |
| 2025-12-31 | 73.68% |
| 2025-09-30 | 70.28% |
| 2025-06-30 | 70.85% |
| 2025-03-31 | 71.13% |
| 2024-12-31 | 102.71% |
| 2024-09-30 | 52.29% |
| 2024-06-30 | 73.55% |
| 2024-03-31 | 76.46% |
| 2023-12-31 | 68.07% |
| 2023-09-30 | 58.68% |
| 2023-06-30 | 63.89% |
| 2023-03-31 | 57.73% |
| 2022-12-31 | 61.31% |
| 2022-09-30 | 30.46% |
| 2022-06-30 | 58.21% |
| 2022-03-31 | 71.26% |
| 2021-12-31 | 74.23% |
| 2021-09-30 | 72.33% |
| 2021-06-30 | 76.15% |
| 2021-03-31 | 72.87% |
| 2020-12-31 | 78.86% |
| 2020-09-30 | 71.79% |
| 2020-06-30 | 65.86% |
| 2020-03-31 | 70.76% |
| 2019-12-31 | 68.32% |
| 2019-09-30 | 70.39% |
| 2019-06-30 | 68.65% |
| 2019-03-31 | 62.01% |
| 2018-12-31 | 61.93% |
| 2018-09-30 | 59.77% |
| 2018-06-30 | 65.96% |
| 2018-03-31 | 64.65% |
| 2017-12-31 | 70.55% |
| 2017-09-30 | 56.02% |
| 2017-06-30 | 51.27% |
| 2017-03-31 | 51.69% |
| 2016-12-31 | 50.36% |
| 2016-09-30 | 55.02% |
| 2016-06-30 | 52.86% |
| 2016-03-31 | 48.71% |
| 2015-12-31 | 46.24% |
| 2015-09-30 | 40.39% |
| 2015-06-30 | 40.66% |
| 2015-03-31 | 56.78% |
| 2014-12-31 | 62.31% |
| 2014-09-30 | 54.00% |
| 2014-06-30 | -0.06% |
| 2014-03-31 | -16.05% |
| 2013-12-31 | -166.79% |
| 2013-09-30 | -204.85% |
| 2013-06-30 | -55.94% |
| 2013-03-31 | -43.96% |
| 2012-12-31 | 109.88% |
| 2012-09-30 | 76.57% |
| 2012-06-30 | 69.49% |
| 2012-03-31 | 40.33% |
| 2011-12-31 | 67.40% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 179.16% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-02-28 | 20.84% |
| 2005-11-30 | 100.00% |
| 2005-08-31 | 100.00% |
| 2005-05-31 | 0.00% |
| 2005-02-28 | 0.00% |
| 2004-11-30 | 0.00% |
